PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
-2.49%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$162M
AUM Growth
+$162M
(-8.3%)
Cap. Flow
-$3.64M
Cap. Flow
% of AUM
-2.25%
Top 10 Holdings %
Top 10 Hldgs %
35.84%
Holding
111
New
5
Increased
11
Reduced
29
Closed
5
Top Buys
| 1 |
SMED
Sharps Compliance Corp
SMED
|
$976K |
| 2 |
Elutia
ELUT
|
$515K |
| 3 |
Inuvo
INUV
|
$480K |
| 4 |
Ooma
OOMA
|
$425K |
| 5 |
Inspira Technologies Oxy
IINN
|
$247K |
Top Sells
| 1 |
CareDx
CDNA
|
$2.67M |
| 2 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$925K |
| 3 |
CEMI
Chembio diagnostics, Inc.
CEMI
|
$796K |
| 4 |
ITMR
Itamar Medical Ltd. American Depository Shares
ITMR
|
$635K |
| 5 |
IIN
IntriCon Corporation
IIN
|
$633K |
Sector Composition
| 1 | Healthcare | 61.72% |
| 2 | Technology | 15.59% |
| 3 | Industrials | 6.78% |
| 4 | Communication Services | 6.55% |
| 5 | Consumer Staples | 3.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
OptimizeRx
OPRX
$335M
| $9.85M | 6.1% | 115,180 -1,250 | -1% | -$107K |
|
2
NeoGenomics
NEO
$1.13B
| $7.61M | 4.71% | 157,750 -550 | -0.3% | -$26.5K |
|
3
Natera
NTRA
$23.1B
| $6.95M | 4.31% | 62,400 -50 | -0.1% | -$5.57K |
|
4
Idexx Laboratories
IDXX
$51.8B
| $6.91M | 4.28% | 11,105 | – | – |
|
5
Veracyte
VCYT
$2.39B
| $5.81M | 3.59% | 124,980 | – | – |
|
6
FlexShopper
FPAY
$17M
| $4.57M | 2.83% | 1,478,870 -500 | -0% | -$1.55K |
|
7
Microsoft
MSFT
$3.77T
| $4.37M | 2.7% | 15,493 | – | – |
|
8
Axogen
AXGN
$743M
| $4.32M | 2.67% | 273,240 +400 | +0.1% | +$6.32K |
|
|
9
CareDx
CDNA
$727M
| $3.83M | 2.37% | 60,442 -42,200 | -41% | -$2.67M |
|
10
Vericel Corp
VCEL
$1.83B
| $3.68M | 2.28% | 75,387 -3,225 | -4% | -$157K |
|
11
Standard BioTools
LAB
$481M
| $3.43M | 2.12% | 520,825 | – | – |
|
|
12
Inuvo
INUV
$49.5M
| $3.38M | 2.09% | 4,833,527 +686,016 | +17% | +$480K |
|
|
STRM
13
DELISTED
Streamline Health Solutions
STRM
| $3.32M | 2.05% | 1,895,450 -42,500 | -2% | -$74.4K |
|
14
Abbott
ABT
$231B
| $3.26M | 2.02% | 27,580 | – | – |
|
15
Eli Lilly
LLY
$657B
| $3.17M | 1.96% | 13,708 | – | – |
|
16
Cantaloupe
CTLP
$797M
| $2.95M | 1.83% | 273,725 -4,250 | -2% | -$45.8K |
|
|
17
Ooma
OOMA
$356M
| $2.83M | 1.75% | 152,075 +22,850 | +18% | +$425K |
|
18
Exagen
XGN
$217M
| $2.81M | 1.74% | 206,230 +5,750 | +3% | +$78.2K |
|
19
LeMaitre Vascular
LMAT
$2.16B
| $2.75M | 1.7% | 51,700 -100 | -0.2% | -$5.31K |
|
20
AtriCure
ATRC
$1.84B
| $2.67M | 1.65% | 38,350 | – | – |
|
21
Digi International
DGII
$1.29B
| $2.66M | 1.64% | 126,300 -500 | -0.4% | -$10.5K |
|
|
CSLT
22
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $2.61M | 1.62% | 1,663,000 +30,000 | +2% | +$47.1K |
|
|
VG
23
DELISTED
Vonage Holdings Corporation
VG
| $2.56M | 1.58% | 158,525 | – | – |
|
24
Pfizer
PFE
$141B
| $2.34M | 1.45% | 54,298 +3,450 | +7% | +$148K |
|
25
Castle Biosciences
CSTL
$696M
| $2.2M | 1.36% | 33,150 | – | – |
|